Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
-
5081
Table 1_Safety and efficacy comparison of single-stage and two-stage ERCP combined with laparoscopic cholecystectomy: a meta-analysis and systematic review.xlsx
Published 2025“…LERV demonstrates superior outcomes compared to the sequential two-step approach of ERCP followed by laparoscopic cholecystectomy (ERCP+LC). …”
-
5082
Table 2_Safety and efficacy comparison of single-stage and two-stage ERCP combined with laparoscopic cholecystectomy: a meta-analysis and systematic review.docx
Published 2025“…LERV demonstrates superior outcomes compared to the sequential two-step approach of ERCP followed by laparoscopic cholecystectomy (ERCP+LC). …”
-
5083
The effect of cognitive behavioral therapy-based psychoeducation on substance abuse proclivity in adolescent smokers
Published 2025“…The difference between the posttest SAPS total mean scores of the control and experimental groups was statistically significant.…”
-
5084
Data for detecting trends in hydroclimatic changes in the Svartberget Krycklan catchment
Published 2024“…Looking at runoff, we have observed increasing baseflow during the winter but decreasing baseflow during the summers. …”
-
5085
Image 2_Astragaloside IV alleviates GDM via regulating gut microbiota and gut microbiota metabolomic.tif
Published 2025“…</p>Results<p>After the 25-day intervention, the GDM model + AS IV group showed significantly decreased fasting blood glucose levels (p = 0.0003), mean insulin levels (p = 0.0001), and insulin resistance index (p = 0.0001). …”
-
5086
Image 1_Astragaloside IV alleviates GDM via regulating gut microbiota and gut microbiota metabolomic.tif
Published 2025“…</p>Results<p>After the 25-day intervention, the GDM model + AS IV group showed significantly decreased fasting blood glucose levels (p = 0.0003), mean insulin levels (p = 0.0001), and insulin resistance index (p = 0.0001). …”
-
5087
Table 1_Astragaloside IV alleviates GDM via regulating gut microbiota and gut microbiota metabolomic.xlsx
Published 2025“…</p>Results<p>After the 25-day intervention, the GDM model + AS IV group showed significantly decreased fasting blood glucose levels (p = 0.0003), mean insulin levels (p = 0.0001), and insulin resistance index (p = 0.0001). …”
-
5088
Table 2_Astragaloside IV alleviates GDM via regulating gut microbiota and gut microbiota metabolomic.xlsx
Published 2025“…</p>Results<p>After the 25-day intervention, the GDM model + AS IV group showed significantly decreased fasting blood glucose levels (p = 0.0003), mean insulin levels (p = 0.0001), and insulin resistance index (p = 0.0001). …”
-
5089
Data_Sheet_1_Investigating the impact of mental rehearsal on prefrontal and motor cortical haemodynamic responses in surgeons using optical neuroimaging.docx
Published 2024“…Mean objective performance score was significantly higher following MR compared with TR (p = 0.043).…”
-
5090
Data Sheet 1_Real world evidence of dupilumab effectiveness in a Colombian cohort of patients diagnosed with severe asthma.docx
Published 2025“…FEV1 measurements after one or two years of dupilumab treatment were significantly lower than baseline (p = 0.03). Mean change from baseline in FEV<sub>1</sub> was 302.1 ± 481.97 ml (n = 19), 282.00 ± 231.99 ml (n = 10), and 248.18 ± 281.21 ml (n = 11) in the 2–4-, 11–13-, and 19–25-month follow-up periods, respectively. …”
-
5091
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5092
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5093
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5094
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5095
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5096
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5097
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5098
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5099
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”
-
5100
First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity
Published 2024“…These sila-analogues show similar VDR binding and transcriptional activity in comparison with the natural hormone 1,25D<sub>3</sub>, but with significantly less hypercalcemic activity. The new analogues, when combined with chemotherapy, significantly decrease cell proliferation.…”